ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,663Medicare Part D Prescriptions Filled, Including Refills

Rank: 119 out of 337

$306K Total Retail Price of All Prescriptions

Rank: 152 out of 337

412 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
25% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Rhode Island
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 412 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

6% of this provider’s 412 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 6,481 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$40 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Rhode Island
SIMVASTATIN 475 429 1 1
OMEPRAZOLE 463 336 2 4
LEVOTHYROXINE SODIUM 462 396 3 5
LISINOPRIL 395 345 4 2
AMLODIPINE BESYLATE 261 236 5 3
HYDROCHLOROTHIAZIDE 230 200 6 9
ATORVASTATIN CALCIUM 175 139 7 7
ATENOLOL 164 145 8 10
SERTRALINE HCL 136 119 9 18
FUROSEMIDE 131 131 10 8
TRIAMTERENE-HCTZ 126 122 11 39
TRAZODONE HCL 121 88 12 16
METFORMIN HCL 115 89 13 12
DIOVAN 112 84 14 26
LOSARTAN POTASSIUM 108 91 15 15
METOPROLOL TARTRATE 107 91 16 6
CITALOPRAM HBR 103 89 17 17
POLYETHYLENE GLYCOL 3350 101 56 18 47
ALENDRONATE SODIUM 100 100 19 19
ZOLPIDEM TARTRATE 93 92 20 23
FLUTICASONE PROPIONATE 90 70 21 34
FLUOXETINE HCL 89 88 22 57
PRAVASTATIN SODIUM 68 46 23 14
VENLAFAXINE HCL ER 68 59 23 86
METOPROLOL SUCCINATE 67 66 25 21
CYMBALTA 67 37 25 59
GLYBURIDE 65 38 R 27 53
LIPITOR 65 51 27 33
SYNTHROID 64 64 29 41
WARFARIN SODIUM 60 59 30 11
HYDROCODONE-ACETAMINOPHEN 60 53 S3 30 13
PROAIR HFA 58 52 32 38
RANITIDINE HCL 57 31 33 30
PANTOPRAZOLE SODIUM 54 54 34 36
OXYBUTYNIN CHLORIDE 50 50 35 143
LOVASTATIN 50 50 35 24
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 24, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.